The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Persistent Hyperinsulinemia Hypoglycemia of Infancy

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Persistent Hyperinsulinemia Hypoglycemia of Infancy

 

High impact information on Persistent Hyperinsulinemia Hypoglycemia of Infancy

  • INTERPRETATION: Heterozygous E1506K substitution in the SUR1 gene causes congenital hyperinsulinism in infancy, loss of insulin secretory capacity in early adulthood, and diabetes in middle-age [4].
  • A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels [5].
  • Our findings reveal a novel molecular mechanism for loss of KATP channel function and congenital hyperinsulinism and support the importance of phospholipids and/or long chain acyl-CoAs in setting the physiological activity of beta-cell KATP channels [5].
  • In conclusion, the loss of ATP-sensitive K(+) channels and or elevated intraislet insulin cannot explain the blunted glucagon release in all patients with congenital hyperinsulinism [1].
  • Identification of regulatory mutations of glutamate dehydrogenase (GDH) in a form of congenital hyperinsulinism (GDH-HI) is providing a model for basal insulin secretion (IS) and amino acid (AA)-stimulated insulin secretion (AASIS) in which glutaminolysis plays a key role [6].
 

Chemical compound and disease context of Persistent Hyperinsulinemia Hypoglycemia of Infancy

 

Biological context of Persistent Hyperinsulinemia Hypoglycemia of Infancy

 

Anatomical context of Persistent Hyperinsulinemia Hypoglycemia of Infancy

 

Gene context of Persistent Hyperinsulinemia Hypoglycemia of Infancy

References

  1. Serum glucagon counterregulatory hormonal response to hypoglycemia is blunted in congenital hyperinsulinism. Hussain, K., Bryan, J., Christesen, H.T., Brusgaard, K., Aguilar-Bryan, L. Diabetes (2005) [Pubmed]
  2. Disorders of glutamate metabolism. Kelly, A., Stanley, C.A. Mental retardation and developmental disabilities research reviews. (2001) [Pubmed]
  3. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Radetti, G., Gentili, L., Paganini, C., Messner, H. Eur. J. Pediatr. (2000) [Pubmed]
  4. A new subtype of autosomal dominant diabetes attributable to a mutation in the gene for sulfonylurea receptor 1. Huopio, H., Otonkoski, T., Vauhkonen, I., Reimann, F., Ashcroft, F.M., Laakso, M. Lancet (2003) [Pubmed]
  5. A novel KCNJ11 mutation associated with congenital hyperinsulinism reduces the intrinsic open probability of beta-cell ATP-sensitive potassium channels. Lin, Y.W., MacMullen, C., Ganguly, A., Stanley, C.A., Shyng, S.L. J. Biol. Chem. (2006) [Pubmed]
  6. Glutaminolysis and insulin secretion: from bedside to bench and back. Kelly, A., Li, C., Gao, Z., Stanley, C.A., Matschinsky, F.M. Diabetes (2002) [Pubmed]
  7. Genotype-phenotype correlations in children with congenital hyperinsulinism due to recessive mutations of the adenosine triphosphate-sensitive potassium channel genes. Henwood, M.J., Kelly, A., Macmullen, C., Bhatia, P., Ganguly, A., Thornton, P.S., Stanley, C.A. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  8. Severe congenital hyperinsulinism caused by a mutation in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium channel impairing trafficking and function. Marthinet, E., Bloc, A., Oka, Y., Tanizawa, Y., Wehrle-Haller, B., Bancila, V., Dubuis, J.M., Philippe, J., Schwitzgebel, V.M. J. Clin. Endocrinol. Metab. (2005) [Pubmed]
  9. Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism. Giurgea, I., Laborde, K., Touati, G., Bellanné-Chantelot, C., Nassogne, M.C., Sempoux, C., Jaubert, F., Khoa, N., Chigot, V., Rahier, J., Brunelle, F., Nihoul-Fékété, C., Dunne, M.J., Stanley, C., Saudubray, J.M., Robert, J.J., de Lonlay, P. J. Clin. Endocrinol. Metab. (2004) [Pubmed]
  10. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. Thornton, P.S., Alter, C.A., Katz, L.E., Baker, L., Stanley, C.A. J. Pediatr. (1993) [Pubmed]
  11. Octreotide in hyperinsulinism. Barrons, R.W. The Annals of pharmacotherapy. (1997) [Pubmed]
  12. Dysregulation of insulin secretion in children with congenital hyperinsulinism due to sulfonylurea receptor mutations. Grimberg, A., Ferry, R.J., Kelly, A., Koo-McCoy, S., Polonsky, K., Glaser, B., Permutt, M.A., Aguilar-Bryan, L., Stafford, D., Thornton, P.S., Baker, L., Stanley, C.A. Diabetes (2001) [Pubmed]
  13. Clinical and molecular characterization of a dominant form of congenital hyperinsulinism caused by a mutation in the high-affinity sulfonylurea receptor. Thornton, P.S., MacMullen, C., Ganguly, A., Ruchelli, E., Steinkrauss, L., Crane, A., Aguilar-Bryan, L., Stanley, C.A. Diabetes (2003) [Pubmed]
  14. Characterisation of new KATP-channel mutations associated with congenital hyperinsulinism in the Finnish population. Reimann, F., Huopio, H., Dabrowski, M., Proks, P., Gribble, F.M., Laakso, M., Otonkoski, T., Ashcroft, F.M. Diabetologia (2003) [Pubmed]
  15. Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11. Fournet, J.C., Mayaud, C., de Lonlay, P., Gross-Morand, M.S., Verkarre, V., Castanet, M., Devillers, M., Rahier, J., Brunelle, F., Robert, J.J., Nihoul-Fékété, C., Saudubray, J.M., Junien, C. Am. J. Pathol. (2001) [Pubmed]
  16. Molecular characterisation of glutamate dehydrogenase gene defects in Japanese patients with congenital hyperinsulinism/hyperammonaemia. Fujioka, H., Okano, Y., Inada, H., Asada, M., Kawamura, T., Hase, Y., Yamano, T. Eur. J. Hum. Genet. (2001) [Pubmed]
  17. Reversible hypertrophic cardiomyopathy in congenital hyperinsulinism. Massin, M.M., Van Elmbt, G., Soyeur, D. Acta cardiologica. (1999) [Pubmed]
 
WikiGenes - Universities